Subjective xerostomia in long-term surviving children and adolescents after pediatric bone marrow transplantation

Transplantation

Volumn 69, Issue 5, 2000, Pages 822-826

  Bågesund, Mats ^a   Winiarski, Jacek ^b   Dahllöf, Göran ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

^b KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ARTICLE; BONE MARROW TRANSPLANTATION; CHILD; DISEASE ASSOCIATION; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SALIVARY GLAND DISEASE; SALIVATION; SURVIVAL TIME; XEROSTOMIA;

EID: 0343963792     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (32)

1. Bortin MM, Horowitz MM, Rimm AA. Increasing utilization of allogeneic bone marrow transplantation: results of the 1988-1990 survey. Ann Intern Med 1992; 116: 505.
2. Gratwohl A, Hermans J, Baldomero H. Blood and marrow transplantation activity in Europe 1995. Bone Marrow Transplant 1997; 19: 407.
3. Sanders JE, Pritchard S, Mahoney P, et al. Growth and development following marrow transplantation for leukemia. Blood 1986; 68: 1129.
4. Borgström B. Endocrinological implications of bone marrow transplantation in childhood: a longitudinal study. Thesis. Karolinska Institutet, Stockholm, 1995.
5. Dahllöf G, Barr M, Bolme P, et al. Disturbances in dental development after total body irradiation in bone marrow transplant recipients. Oral Surg Oral Med Oral Pathol 1988; 65: 41.
6. Näsman M, Forsberg CM, Dahllöf G. Long-term dental development in children after treatment for malignant disease. Eur J Orthod 1997; 19: 151.
7. Dahllöf G, Bågesund M, Ringdén O. Impact of conditioning regimens on salivary function, caries-associated microorganisms and dental caries in children treated with bone marrow transplantation. A four-year longitudinal study. Bone Marrow Transplant 1997; 20: 479.
8. Sreebny LM, Valdini A. Xerostomia. Part I: Relationship to other oral symptoms and salivary gland hypofunction. Oral Surg Oral Med Oral Pathol 1988; 66: 451.
9. Sreebny LM, Valdini A, Yu A. Xerostomia. Part II: Relationship to nonoral symptoms, drugs, and diseases. Oral Surg Oral Med Oral Pathol 1989; 68: 419.
10. Greenspan D. Xerostomia: diagnosis and management. Oncology 1996; 10(Suppl 3): 7.
11. Billings RJ, Proskin HM, Moss ME. Xerostomia and associated factors in a community-dwelling adult population. Community Dent Oral Epidemiol 1996; 24: 312.
12. Manthorpe R. Axéll T. Xerostomia. Clin Exp Rheumatol 1990; 8 (Suppl. 5): 7.
13. nd ed. British Dental Journal, London 1996. p. 27.
14. Crossner CG. Salivary flow rate in children and adolescents. Swed Dent J 1984; 8: 271.
15. Fox PC, Busch KA, Baum BJ. Subjective reports of xerostomia and objective measures of salivary gland performance. J Am Dent Assoc 1987; 115: 581.
16. Altman DG, Practical statistics for medical research. Chapman & Hall, London 1991; 179.
17. Dahllöf G, Barr M, Heimdahl A, Mattsson T, Ringdén O. Oral ulceration and infection during the neutropenic phase in children and adults treated by bone-marrow transplantation. J Paed Dent 1990; 6: 109.
18. Dahllöf G, Forsberg CM, Ringdén O, et al. Facial growth and morphology in long-term survivors after bone marrow transplantation. Eur J Orthod 1989; 11: 332.
19. Näsman M, Björk O, Söderhäll S, Ringdén O, Dahllöf G. Disturbances in the oral cavity in pediatric long-term survivors after different forms of antineoplastic therapy. Pediatr Dent 1994; 16: 217.
20. Dahllöf G, Krekmanova L, Kopp S, Borgström B, Forsberg CM, Ringdén O. Craniomandibular dysfunction in children treated with total-body irradiation and bone marrow transplantation. Acta Odontol Scand 1994; 52: 99.
21. Uderzo C, Fraschini D, Balduzzi A, et al. Long-term effects of bone marrow transplantation on dental status in children with leukemia. Bone Marrow Transplant 1997; 20: 865.
22. Dahllöf G, Bågesund M, Remberger M, Ringdén O. Risk factors for salivary dysfunction in children 1 year after bone marrow transplantation. Oral Oncol 1997; 33: 327.
23. Vitali C, Bombardieri S. Diagnostic criteria for Sjögren's syndrome: the state of the art. Clin Exp Rheumatol 1990; 8(Suppl. 5): 13.
24. Dawes C. Physiological factors affecting salivary flow rate, oral sugar clearance and the sensation of dry mouth in man. J Dent Res 1987; 66: 648.
25. Nagler R, Marmary Y, Krausz Y, Chisin R, Markitziu A, Nagler A. Major salivary gland dysfunction in human acute and chronic graft-versus-host disease (GVHD). Bone Marrow Transplant 1996; 17: 219.
26. Nederfors T, Isaksson R, Mörnstad H, Dahlöf C. Prevalence of perceived symptoms of dry mouth in an adult Swedish population: relation to age, sex and pharmacotherapy. Community Dent Oral Epidemiol 1997; 25: 211.
27. Nederfors T. Xerostomia: Prevalence and pharmacotherapy with special reference to β-adrenoceptor antagonists. Thesis. Göteborg University. Swed Dent J 1996; Suppl 116: 9.
28. Baum BJ, Bodner L, Fox PC, Izutsu KT, Pizzo PA, Wright WE. Therapy-induced dysfunction of salivary glands: implications for oral health. Spec Care Dent 1985; 5: 274.
29. Forsgren S, Franzén L, Funegård H, Gustafsson H, Henriksson R. Bilateral irradiation of head and neck induces an enhanced expression of substance P in the parasympathetic innervation of the submandibular gland. Neuroscience 1992; 46: 233.
30. Franzén L, Sundström S, Karlsson M, Gustafsson H, Littbrand B, Henriksson R. Fractionated irradiation and early changes in noradrenaline induced potassium efflux (86Rb+) in rat parotid gland. Acta Oncol 1992; 31: 359.
31. Nederfors T, Henricsson V, Axéll T, Dahlöf C. Oral mucosal friction and subjective perception of dry mouth in relation to salivary secretion. Scand J Dent Res 1993; 101: 44.
32. Guchelaar HJ, Vermes A, Meerwaldt JH. Radiation induced xerostomia: pathophysiology, clinical course and supportive treatment. Support Care Cancer 1997; 5: 281.